Investing
The company's AI platform schedules patient appointments and fields questions 24/7.
The company will use the funding to further develop its SmartShunt System, aimed at reducing shunt failures and improving care for patients with hydrocephalus.
Also, Singapore has approved a lung cancer imaging AI platform.
The company will use the funds to expand access to its AI-driven platform that allows providers to access and organize patient medical records.
The company closes a $400 million private placement, with potential proceeds of $1 billion, and announces plans to establish a Solana-based digital asset treasury strategy.
The AI-powered engagement platform connects immigrant workforces to services, such as healthcare, jobs with U.S. employers and financial tools.
Barti Software scores $12 million for AI-powered EHR software for ophthalmologists, and Sleep.ai secures $5.5 million for sleep technology.
The private equity firm signed a definitive agreement to acquire PatientPoint from an investor group led by L Catterton and Littlejohn & Co.
The acquisition will allow Tempus to expand its technical team and create a stronger presence in digital pathology.
British Growth Fund’s exit marks one of the largest for a UK medtech company and the most profitable return in the firm’s history.